Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence in surgery. Reducing the risks related to polypharmacy in perioperative period
0
Zitationen
3
Autoren
2025
Jahr
Abstract
In recent years, active development of artificial intelligence (AI) leads to its widespread introduction into various spheres of human activity, including healthcare and surgery. The ongoing research of AI in surgery is aimed at potential benefits of AI at all stages of examination and treatment of patients. The ultimate goal is improvement of quality, effectiveness and safety of treatment. This review examines the main directions of AI (machine learning, natural language processing, artificial neural networks, computer vision) and provides examples of their current use including reducing the risks of polypharmacy in perioperative period. The prospects for further development of AI in surgery and possible risks associated with this technology are also discussed.
Ähnliche Arbeiten
Classification of Surgical Complications
2004 · 30.218 Zit.
2013 ESH/ESC Guidelines for the management of arterial hypertension
2013 · 13.648 Zit.
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 · 13.436 Zit.
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 · 13.234 Zit.
2013 ACCF/AHA Guideline for the Management of Heart Failure
2013 · 12.583 Zit.